Cargando…

A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)

SCOPE: As prostaglandin E2 (PGE(2)) has important roles in physiological and inflammatory functions, a double-blind randomized controlled crossover study to investigate the potential of nasturtium (Tropaeolum majus) for modulating PGE(2) was conducted, aiming at clarifying the role of benzyl isothio...

Descripción completa

Detalles Bibliográficos
Autores principales: Herz, Corinna, Frei, Linda, Tran, Hoai T. T., Claßen, Sophie, Spöttel, Jenny, Krell, Mareike, Hanschen, Franziska S., Arvandi, Marjan, Binder, Nadine, Schreiner, Monika, Rohn, Sascha, Lamy, Evelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434789/
https://www.ncbi.nlm.nih.gov/pubmed/37599682
http://dx.doi.org/10.3389/fnut.2023.1223158
_version_ 1785091983959654400
author Herz, Corinna
Frei, Linda
Tran, Hoai T. T.
Claßen, Sophie
Spöttel, Jenny
Krell, Mareike
Hanschen, Franziska S.
Arvandi, Marjan
Binder, Nadine
Schreiner, Monika
Rohn, Sascha
Lamy, Evelyn
author_facet Herz, Corinna
Frei, Linda
Tran, Hoai T. T.
Claßen, Sophie
Spöttel, Jenny
Krell, Mareike
Hanschen, Franziska S.
Arvandi, Marjan
Binder, Nadine
Schreiner, Monika
Rohn, Sascha
Lamy, Evelyn
author_sort Herz, Corinna
collection PubMed
description SCOPE: As prostaglandin E2 (PGE(2)) has important roles in physiological and inflammatory functions, a double-blind randomized controlled crossover study to investigate the potential of nasturtium (Tropaeolum majus) for modulating PGE(2) was conducted, aiming at clarifying the role of benzyl isothiocyanate (BITC). As secondary parameters leukotriene 4 (LTB(4)), and cytokine release (tumor necrosis factor alpha, TNF-α; interleukins IL-1β, IL-10, and IL-12) were quantified. METHODS AND RESULTS: Thirty-four healthy female participants consumed 1.5 g nasturtium containing BITC, (verum) or no BITC (control) twice a day for 2 weeks each. Nasturtium intervention resulted in an increase in mean PGE(2) levels in serum samples (verum: 1.76-fold, p ≤ 0.05; control: 1.78-fold, p ≤ 0.01), and ex vivo stimulated peripheral blood mononuclear cells (PBMC) (verum: 1.71-fold, p ≤ 0.01; control: 1.43-fold). Using a pre-to-post responder analysis approach, 18 of 34 subjects showed a > 25% PGE(2) increase in serum, while it was >25% decreased for 9 subjects (stimulated PBMC: 14 and 8 of 28, respectively). Under the selected conditions, the BITC content of nasturtium did not affect the observed changes in PGE(2). Verum intervention also increased mean LTB(4) serum level (1.24-fold, p ≤ 0.01), but not in LPS stimulated PBMC, and significantly increased TNF-α release in stimulated PBMC after 3 h (verum: 1.65-fold, p = 0.0032; control: 1.22-fold, p = 0.7818). No change was seen in the anti-inflammatory cytokine IL-10, or the pro-inflammatory cytokines IL-1β, and IL-12. CONCLUSION: In contrast to the previously reported in vitro results, on average, LPS activated PBMC and serum from both groups showed increased PGE(2) levels. Further analyses suggest that PGE(2) release after intervention could possibly depend on the baseline PGE(2) level. Identification of phenotypes that respond differently to the nasturtium intervention could be useful to establish personalized approaches for dosing phytopharmaceuticals medicines.
format Online
Article
Text
id pubmed-10434789
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104347892023-08-18 A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2) Herz, Corinna Frei, Linda Tran, Hoai T. T. Claßen, Sophie Spöttel, Jenny Krell, Mareike Hanschen, Franziska S. Arvandi, Marjan Binder, Nadine Schreiner, Monika Rohn, Sascha Lamy, Evelyn Front Nutr Nutrition SCOPE: As prostaglandin E2 (PGE(2)) has important roles in physiological and inflammatory functions, a double-blind randomized controlled crossover study to investigate the potential of nasturtium (Tropaeolum majus) for modulating PGE(2) was conducted, aiming at clarifying the role of benzyl isothiocyanate (BITC). As secondary parameters leukotriene 4 (LTB(4)), and cytokine release (tumor necrosis factor alpha, TNF-α; interleukins IL-1β, IL-10, and IL-12) were quantified. METHODS AND RESULTS: Thirty-four healthy female participants consumed 1.5 g nasturtium containing BITC, (verum) or no BITC (control) twice a day for 2 weeks each. Nasturtium intervention resulted in an increase in mean PGE(2) levels in serum samples (verum: 1.76-fold, p ≤ 0.05; control: 1.78-fold, p ≤ 0.01), and ex vivo stimulated peripheral blood mononuclear cells (PBMC) (verum: 1.71-fold, p ≤ 0.01; control: 1.43-fold). Using a pre-to-post responder analysis approach, 18 of 34 subjects showed a > 25% PGE(2) increase in serum, while it was >25% decreased for 9 subjects (stimulated PBMC: 14 and 8 of 28, respectively). Under the selected conditions, the BITC content of nasturtium did not affect the observed changes in PGE(2). Verum intervention also increased mean LTB(4) serum level (1.24-fold, p ≤ 0.01), but not in LPS stimulated PBMC, and significantly increased TNF-α release in stimulated PBMC after 3 h (verum: 1.65-fold, p = 0.0032; control: 1.22-fold, p = 0.7818). No change was seen in the anti-inflammatory cytokine IL-10, or the pro-inflammatory cytokines IL-1β, and IL-12. CONCLUSION: In contrast to the previously reported in vitro results, on average, LPS activated PBMC and serum from both groups showed increased PGE(2) levels. Further analyses suggest that PGE(2) release after intervention could possibly depend on the baseline PGE(2) level. Identification of phenotypes that respond differently to the nasturtium intervention could be useful to establish personalized approaches for dosing phytopharmaceuticals medicines. Frontiers Media S.A. 2023-08-03 /pmc/articles/PMC10434789/ /pubmed/37599682 http://dx.doi.org/10.3389/fnut.2023.1223158 Text en Copyright © 2023 Herz, Frei, Tran, Claßen, Spöttel, Krell, Hanschen, Arvandi, Binder, Schreiner, Rohn and Lamy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Herz, Corinna
Frei, Linda
Tran, Hoai T. T.
Claßen, Sophie
Spöttel, Jenny
Krell, Mareike
Hanschen, Franziska S.
Arvandi, Marjan
Binder, Nadine
Schreiner, Monika
Rohn, Sascha
Lamy, Evelyn
A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)
title A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)
title_full A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)
title_fullStr A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)
title_full_unstemmed A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)
title_short A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E(2)
title_sort monocentric, randomized, double-blind, controlled crossover trial of nasturtium (tropaeolum majus) on the lipid regulator prostaglandin e(2)
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434789/
https://www.ncbi.nlm.nih.gov/pubmed/37599682
http://dx.doi.org/10.3389/fnut.2023.1223158
work_keys_str_mv AT herzcorinna amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT freilinda amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT tranhoaitt amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT claßensophie amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT spotteljenny amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT krellmareike amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT hanschenfranziskas amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT arvandimarjan amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT bindernadine amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT schreinermonika amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT rohnsascha amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT lamyevelyn amonocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT herzcorinna monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT freilinda monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT tranhoaitt monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT claßensophie monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT spotteljenny monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT krellmareike monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT hanschenfranziskas monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT arvandimarjan monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT bindernadine monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT schreinermonika monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT rohnsascha monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2
AT lamyevelyn monocentricrandomizeddoubleblindcontrolledcrossovertrialofnasturtiumtropaeolummajusonthelipidregulatorprostaglandine2